Nanomedicine for Inflammatory Diseases
portes grátis
Nanomedicine for Inflammatory Diseases
Milane, Lara Scheherazade; Amiji, Mansoor M.
Taylor & Francis Ltd
03/2021
372
Mole
Inglês
9780367657833
15 a 20 dias
690
Descrição não disponível.
Part I * Introduction: Introduction
to Inflammatory Disease,
Nanomedicine, and
Translational Nanomedicine
1 * FUNDAMENTALS OF IMMUNOLOGY
AND INFLAMMATION
2 * PRINCIPLES OF NANOMEDICINE
3 * NANOTOXICITY
4 * TRANSLATIONAL NANOMEDICINE
Part II * Introduction: Primary
Inflammatory Disease
5.1 * BIOLOGY AND CLINICAL TREATMENT
OF INFLAMMATORY BOWEL DISEASE
5.2 * NANOTHERAPEUTICS FOR
INFLAMMATORY BOWEL DISEASE
5.3 * BRIDGING THE GAP BETWEEN
THE BENCH AND THE CLINIC:
INFLAMMATORY BOWEL DISEASE
6.1 * THE BIOLOGY AND CLINICAL
TREATMENT OF MULTIPLE SCLEROSIS
6.2 * NANOTHERAPEUTICS FOR MULTIPLE
SCLEROSIS
6.3 * BRIDGING THE GAP BETWEEN THE
BENCH AND THE CLINIC
7.1 * THE BIOLOGY AND CLINICAL
TREATMENT OF ASTHMA
7.2 * NANOTHERAPEUTICS FOR ASTHMA
7.3 * BRIDGING THE GAP BETWEEN THE
BENCH AND THE CLINIC: ASTHMA
Part III * Introduction:
The Emerging Role
of Inflammation
in Common Diseases
8 * NEURODEGENERATIVE DISEASE
9 * CANCER
10 * DIABETES
11 * CONCLUDING REMARKS
to Inflammatory Disease,
Nanomedicine, and
Translational Nanomedicine
1 * FUNDAMENTALS OF IMMUNOLOGY
AND INFLAMMATION
2 * PRINCIPLES OF NANOMEDICINE
3 * NANOTOXICITY
4 * TRANSLATIONAL NANOMEDICINE
Part II * Introduction: Primary
Inflammatory Disease
5.1 * BIOLOGY AND CLINICAL TREATMENT
OF INFLAMMATORY BOWEL DISEASE
5.2 * NANOTHERAPEUTICS FOR
INFLAMMATORY BOWEL DISEASE
5.3 * BRIDGING THE GAP BETWEEN
THE BENCH AND THE CLINIC:
INFLAMMATORY BOWEL DISEASE
6.1 * THE BIOLOGY AND CLINICAL
TREATMENT OF MULTIPLE SCLEROSIS
6.2 * NANOTHERAPEUTICS FOR MULTIPLE
SCLEROSIS
6.3 * BRIDGING THE GAP BETWEEN THE
BENCH AND THE CLINIC
7.1 * THE BIOLOGY AND CLINICAL
TREATMENT OF ASTHMA
7.2 * NANOTHERAPEUTICS FOR ASTHMA
7.3 * BRIDGING THE GAP BETWEEN THE
BENCH AND THE CLINIC: ASTHMA
Part III * Introduction:
The Emerging Role
of Inflammation
in Common Diseases
8 * NEURODEGENERATIVE DISEASE
9 * CANCER
10 * DIABETES
11 * CONCLUDING REMARKS
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Eosinophilic Esophagitis;Translational Nanomedicine;Translational medicine;CNS Delivery;Arthritis, asthma, multiple sclerosis, inflammatory bowel disease, diabetes;IBD Patient;Nanotechnology;Solid Lipid Nanoparticles;Immunology and autoimmune diseases;Drug Delivery;Cancer and Oncology;IBD Therapy;Alzheimer's and Gerontology;MS Patient;Michael E. Woods;Airway Inflammation;Wilson S. Meng;Nanomedicine Development;Jelena M. Janjic;IBD;Angie S. Morris;IBD Pathogenesis;Aliasger K. Salem;Th17 Cells;Christopher J. Moran;Autologous HSCT;Bobby J. Cherayil;Copper Oxide Nanoparticles;Bo Xiao;Polymeric Micelles;Didier Merlin;CNS Drug Delivery;Susan Hua;Cancer Stem Cells;Mahsa Khayat-Khoei;M1 Macrophage;Leorah Freeman;Tumor Microenvironment;John Lincoln;John Cunningham Virus;Yonghao Cao;Treg Cells;Joyce J. Pan;EAE Model;Inna Tabansky;Allergic Airway Inflammation;Souhel Najjar;Asthma Model;Paul Wright;Joel N. H. Stern;Mark Messina;Maya Shabbir;Rima Kandil;Jon R. Felt;Prashant Mahajan;Olivia M. Merkel;Adriana Lopes da Silva;Fernanda Ferreira Cruz;Patricia Rieken Macedo Rocco;Yuran Xie;Neha N. Parayath;Grishma Pawar;Charul Avachat;Marcel Menon Miyake;Benjamin Bleier;Mansoor M. Amiji;Antonio J. Ribeiro;Marlene Lopes;Raquel Monteiro;Gaia Cilloni;Francisco Veiga;P. Arnaud
Part I * Introduction: Introduction
to Inflammatory Disease,
Nanomedicine, and
Translational Nanomedicine
1 * FUNDAMENTALS OF IMMUNOLOGY
AND INFLAMMATION
2 * PRINCIPLES OF NANOMEDICINE
3 * NANOTOXICITY
4 * TRANSLATIONAL NANOMEDICINE
Part II * Introduction: Primary
Inflammatory Disease
5.1 * BIOLOGY AND CLINICAL TREATMENT
OF INFLAMMATORY BOWEL DISEASE
5.2 * NANOTHERAPEUTICS FOR
INFLAMMATORY BOWEL DISEASE
5.3 * BRIDGING THE GAP BETWEEN
THE BENCH AND THE CLINIC:
INFLAMMATORY BOWEL DISEASE
6.1 * THE BIOLOGY AND CLINICAL
TREATMENT OF MULTIPLE SCLEROSIS
6.2 * NANOTHERAPEUTICS FOR MULTIPLE
SCLEROSIS
6.3 * BRIDGING THE GAP BETWEEN THE
BENCH AND THE CLINIC
7.1 * THE BIOLOGY AND CLINICAL
TREATMENT OF ASTHMA
7.2 * NANOTHERAPEUTICS FOR ASTHMA
7.3 * BRIDGING THE GAP BETWEEN THE
BENCH AND THE CLINIC: ASTHMA
Part III * Introduction:
The Emerging Role
of Inflammation
in Common Diseases
8 * NEURODEGENERATIVE DISEASE
9 * CANCER
10 * DIABETES
11 * CONCLUDING REMARKS
to Inflammatory Disease,
Nanomedicine, and
Translational Nanomedicine
1 * FUNDAMENTALS OF IMMUNOLOGY
AND INFLAMMATION
2 * PRINCIPLES OF NANOMEDICINE
3 * NANOTOXICITY
4 * TRANSLATIONAL NANOMEDICINE
Part II * Introduction: Primary
Inflammatory Disease
5.1 * BIOLOGY AND CLINICAL TREATMENT
OF INFLAMMATORY BOWEL DISEASE
5.2 * NANOTHERAPEUTICS FOR
INFLAMMATORY BOWEL DISEASE
5.3 * BRIDGING THE GAP BETWEEN
THE BENCH AND THE CLINIC:
INFLAMMATORY BOWEL DISEASE
6.1 * THE BIOLOGY AND CLINICAL
TREATMENT OF MULTIPLE SCLEROSIS
6.2 * NANOTHERAPEUTICS FOR MULTIPLE
SCLEROSIS
6.3 * BRIDGING THE GAP BETWEEN THE
BENCH AND THE CLINIC
7.1 * THE BIOLOGY AND CLINICAL
TREATMENT OF ASTHMA
7.2 * NANOTHERAPEUTICS FOR ASTHMA
7.3 * BRIDGING THE GAP BETWEEN THE
BENCH AND THE CLINIC: ASTHMA
Part III * Introduction:
The Emerging Role
of Inflammation
in Common Diseases
8 * NEURODEGENERATIVE DISEASE
9 * CANCER
10 * DIABETES
11 * CONCLUDING REMARKS
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Eosinophilic Esophagitis;Translational Nanomedicine;Translational medicine;CNS Delivery;Arthritis, asthma, multiple sclerosis, inflammatory bowel disease, diabetes;IBD Patient;Nanotechnology;Solid Lipid Nanoparticles;Immunology and autoimmune diseases;Drug Delivery;Cancer and Oncology;IBD Therapy;Alzheimer's and Gerontology;MS Patient;Michael E. Woods;Airway Inflammation;Wilson S. Meng;Nanomedicine Development;Jelena M. Janjic;IBD;Angie S. Morris;IBD Pathogenesis;Aliasger K. Salem;Th17 Cells;Christopher J. Moran;Autologous HSCT;Bobby J. Cherayil;Copper Oxide Nanoparticles;Bo Xiao;Polymeric Micelles;Didier Merlin;CNS Drug Delivery;Susan Hua;Cancer Stem Cells;Mahsa Khayat-Khoei;M1 Macrophage;Leorah Freeman;Tumor Microenvironment;John Lincoln;John Cunningham Virus;Yonghao Cao;Treg Cells;Joyce J. Pan;EAE Model;Inna Tabansky;Allergic Airway Inflammation;Souhel Najjar;Asthma Model;Paul Wright;Joel N. H. Stern;Mark Messina;Maya Shabbir;Rima Kandil;Jon R. Felt;Prashant Mahajan;Olivia M. Merkel;Adriana Lopes da Silva;Fernanda Ferreira Cruz;Patricia Rieken Macedo Rocco;Yuran Xie;Neha N. Parayath;Grishma Pawar;Charul Avachat;Marcel Menon Miyake;Benjamin Bleier;Mansoor M. Amiji;Antonio J. Ribeiro;Marlene Lopes;Raquel Monteiro;Gaia Cilloni;Francisco Veiga;P. Arnaud
